Mariann H. Byerwalter
Known title: DirectorCIK: 0001233561
Associated companies
Transaction History
| BEN | ▲ Buy | Grant | 7,593 | $205K | 2/3/2026 | View on chart |
| BEN | ▲ Buy | Grant | 9,371 | $195K | 2/4/2025 | View on chart |
| BEN | ▲ Buy | Grant | 7,323 | $195K | 2/6/2024 | View on chart |
| BEN | ▼ Sell | Open Market | 6,011 | $144K | 10/10/2023 | View on chart |
| BEN | ▲ Buy | Grant | 4,982 | $160K | 2/7/2023 | View on chart |
| BEN | ▼ Sell | Open Market | 3,135 | $73K | 6/15/2022 | View on chart |
| BEN | ▲ Buy | Grant | 5,512 | $160K | 2/23/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Barclays cuts Franklin Templeton price target to $34
Barclays lowered its price target for Franklin Templeton to $34 while keeping an Equal-Weight rating. This follows recent news about the firm expanding its asset-backed finance capabilities with Benefit Street Partners. The stock is currently trading near its 52-week low, with an average analyst target of $35.46.
Barclays cuts Franklin Templeton price target to $34. Barclays lowered its price target for Franklin Templeton to $34 while keeping an Equal-Weight rating. This follows recent news about the firm expanding its asset-backed finance capabilities with Benefit Street Partners. The stock is currently trading near its 52-week low, with an average analyst target of $35.46.